Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial

BACKGROUND: Induction chemotherapy regimens of docetaxel and cisplatin plus fluorouracil (TPF) are currently clinically used for patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC) but have well-known side effects, such as myelosuppression and diarrhea. A docetaxel plus cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Wang, Chengtao, He, Shasha, Bai, Li, Kong, Fei, Wang, Siyang, Cui, Lei, Qin, Qiang, Yang, Yunying, Xiao, Wei, Zhu, Meiyan, Zhang, Zeyu, Lai, Yulin, Bao, Wenjing, Peng, Zhenwei, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433608/
https://www.ncbi.nlm.nih.gov/pubmed/36060517
http://dx.doi.org/10.1016/j.eclinm.2022.101625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433608/
https://www.ncbi.nlm.nih.gov/pubmed/36060517
http://dx.doi.org/10.1016/j.eclinm.2022.101625

Ejemplares similares